Lupin gets 3 observations from USFDA for its Tarapur facility

The inspection of Tarapur facility was carried out by the United States Food and Drug administration (USFDA) between September 16-20, 2019.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news